SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-13-000025
Filing Date
2013-05-08
Accepted
2013-05-08 16:35:18
Documents
2
Period of Report
2013-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx05082013.htm 8-K 33160
2 EX-10.1 ex-101.htm EX-10.1 90159
  Complete submission text file 0000875320-13-000025.txt   124656
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 13825020
SIC: 2834 Pharmaceutical Preparations